-
1
-
-
2942729608
-
Management of chronic obstructive pulmonary disease
-
Sutherland ER, Cherniack RM. Management of chronic obstructive pulmonary disease. N Engl J Med 2004;350:2689-2697.
-
(2004)
N Engl J Med
, vol.350
, pp. 2689-2697
-
-
Sutherland, E.R.1
Cherniack, R.M.2
-
2
-
-
33847172367
-
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
-
DOI 10.1056/NEJMoa063070
-
Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356:775-789. (Pubitemid 46294610)
-
(2007)
New England Journal of Medicine
, vol.356
, Issue.8
, pp. 775-789
-
-
Calverley, P.M.A.1
Anderson, J.A.2
Celli, B.3
Ferguson, G.T.4
Jenkins, C.5
Jones, P.W.6
Yates, J.C.7
Vestbo, J.8
-
3
-
-
0034802767
-
Considerations in the evaluation of surrogate endpoints in clinical trials. Summary of a national institutes of health workshop
-
De Gruttola VG, Clax P, DeMets DL, Downing GJ, Ellenberg SS, Friedman L, Gail MH, Prentice R, Wittes J, Zeger SL. Considerations in the evaluation of surrogate endpoints in clinical trials. Summary of a national institutes of health workshop. Control Clin Trials 2001;22: 485-502.
-
(2001)
Control Clin Trials
, vol.22
, pp. 485-502
-
-
De Gruttola, V.G.1
Clax, P.2
Demets, D.L.3
Downing, G.J.4
Ellenberg, S.S.5
Friedman, L.6
Gail, M.H.7
Prentice, R.8
Wittes, J.9
Zeger, S.L.10
-
4
-
-
0033603794
-
Users' guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points: evidence-based medicine working group
-
Bucher HC, Guyatt GH, Cook DJ, Holbrook A, McAlister FA. Users' guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points: evidence-based medicine working group. JAMA 1999;282:771-778.
-
(1999)
JAMA
, vol.282
, pp. 771-778
-
-
Bucher, H.C.1
Guyatt, G.H.2
Cook, D.J.3
Holbrook, A.4
Mcalister, F.A.5
-
5
-
-
70349141385
-
U.S. Department of health and human services food and drug administration center for drug evaluation and research (CDER)
-
accessed April 14, 2009. Available from
-
U.S. Department of health and human services food and drug administration center for drug evaluation and research (CDER). Guidance for industry chronic obstructive pulmonary disease: Developing drugs for treatment. 2007 [accessed April 14, 2009]. Available from: http:// www.fda.gov/CDER/GUIDANCE/7875dft.pdf.
-
(2007)
Guidance for Industry Chronic Obstructive Pulmonary Disease: Developing Drugs for Treatment
-
-
-
6
-
-
33744990865
-
ABC of chronic obstructive pulmonary disease: Diagnosis
-
Currie GP, Legge JS. ABC of chronic obstructive pulmonary disease: diagnosis. BMJ 2006;332:1261-1263. (Pubitemid 44365420)
-
(2006)
British Medical Journal
, vol.332
, Issue.7552
, pp. 1261-1263
-
-
Currie, G.P.1
Legge, J.S.2
-
7
-
-
0025331018
-
Abnormal pulmonary function specifically related to congestive heart failure: Comparison of patients before and after cardiac transplantation
-
DOI 10.1016/0002-9343(90)90428-G
-
Hosenpud JD, Stibolt TA, Atwal K, Shelley D. Abnormal pulmonary function specifically related to congestive heart failure: comparison of patients before and after cardiac transplantation. Am J Med 1990;88:493-496. (Pubitemid 20168725)
-
(1990)
American Journal of Medicine
, vol.88
, Issue.5
, pp. 493-496
-
-
Hosenpud, J.D.1
Stibolt, T.A.2
Atwal, K.3
Shelley, D.4
-
8
-
-
33646565124
-
Outcomes and markers in the assessment of chronic obstructive pulmonary disease
-
DOI 10.1183/09031936.06.00145104
-
Jones PW, Agusti AG. Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur Respir J 2006;27:822-832. (Pubitemid 44914209)
-
(2006)
European Respiratory Journal
, vol.27
, Issue.4
, pp. 822-832
-
-
Jones, P.W.1
Agusti, A.G.N.2
-
9
-
-
40649117704
-
Outcomes for COPD pharmacological trials: From lung function to biomarkers
-
Cazzola M, MacNee W, Martinez FJ, Rabe KF, Franciosi LG, Barnes PJ, Brusasco V, Burge PS, Calverley PM, Celli BR, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 2008;31:416-469.
-
(2008)
Eur Respir J
, vol.31
, pp. 416-469
-
-
Cazzola, M.1
MacNee, W.2
Martinez, F.J.3
Rabe, K.F.4
Franciosi, L.G.5
Barnes, P.J.6
Brusasco, V.7
Burge, P.S.8
Calverley, P.M.9
Celli, B.R.10
-
10
-
-
0242577949
-
Contemporary Management of Chronic Obstructive Pulmonary Disease: Scientific Review
-
DOI 10.1001/jama.290.17.2301
-
Sin DD, McAlister FA, Man SF, Anthonisen NR. Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA 2003;290:2301-2312. (Pubitemid 37430563)
-
(2003)
Journal of the American Medical Association
, vol.290
, Issue.17
, pp. 2301-2312
-
-
Sin, D.D.1
McAlister, F.A.2
Man, S.F.P.3
Anthonisen, N.R.4
-
11
-
-
21744444157
-
Bronchodilator response in the lung health study over 11 yrs
-
DOI 10.1183/09031936.05.00102604
-
Anthonisen NR, Lindgren PG, Tashkin DP, Kanner RE, Scanlon PD, Connett JE. Bronchodilator response in the lung health study over 11 yrs. Eur Respir J 2005;26:45-51. (Pubitemid 40945930)
-
(2005)
European Respiratory Journal
, vol.26
, Issue.1
, pp. 45-51
-
-
Anthonisen, N.R.1
Lindgren, P.G.2
Tashkin, D.P.3
Kanner, R.E.4
Scanlon, P.D.5
Connett, J.E.6
-
12
-
-
57349122437
-
Quantitative computed tomography assessment of airway wall dimensions: Current status and potential applications for pheno-typing chronic obstructive pulmonary disease
-
Coxson HO. Quantitative computed tomography assessment of airway wall dimensions: current status and potential applications for pheno-typing chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008;5:940-945.
-
(2008)
Proc Am Thorac Soc
, vol.5
, pp. 940-945
-
-
Coxson, H.O.1
-
13
-
-
45149088260
-
Inter-relationships between inflammatory markers in patients with stable COPD with bronchitis: Intra-patient and inter-patient variability
-
DOI 10.1136/thx.2007.086751
-
Sapey E, Bayley D, Ahmad A, Newbold P, Snell N, Stockley RA. Interrelationships between inflammatory markers in patients with stable COPD with bronchitis: intra-patient and inter-patient variability. Thorax 2008;63:493-499. (Pubitemid 351831157)
-
(2008)
Thorax
, vol.63
, Issue.6
, pp. 493-499
-
-
Sapey, E.1
Bayley, D.2
Ahmad, A.3
Newbold, P.4
Snell, N.5
Stockley, R.A.6
-
14
-
-
0036729062
-
Standardised methodology of sputuminduction and processing: Future directions
-
Vignola AM, Rennar SI, Hargreave FE, Fah JV, Bonsignore MR, Djukanovic R, Sterk PJ. Standardised methodology of sputuminduction and processing: future directions. Eur Respir J Suppl 2002;37:51s-55s.
-
(2002)
Eur Respir J Suppl
, vol.37
-
-
Vignola, A.M.1
Rennar, S.I.2
Hargreave, F.E.3
Fah, J.V.4
Bonsignore, M.R.5
Djukanovic, R.6
Sterk, P.J.7
-
15
-
-
33646575644
-
Emerging drugs for the treatment of chronic obstructive pulmonary disease
-
DOI 10.1517/14728214.11.2.275
-
Malhotra S, Man SF, Sin DD. Emerging drugs for the treatment of chronic obstructive pulmonary disease. Expert Opin Emerg Drugs 2006;11:275-291. (Pubitemid 43723309)
-
(2006)
Expert Opinion on Emerging Drugs
, vol.11
, Issue.2
, pp. 275-291
-
-
Malhotra, S.1
Man, S.F.P.2
Sin, D.D.3
-
16
-
-
42949146028
-
Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE)
-
Vestbo J, Anderson W, Coxson HO, Crim C, Dawber F, Edwards L, Hagan G, Knobil K, Lomas DA, MacNee W, et al. Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE). Eur Respir J 2008;31:869-873.
-
(2008)
Eur Respir J
, vol.31
, pp. 869-873
-
-
Vestbo, J.1
Anderson, W.2
Coxson, H.O.3
Crim, C.4
Dawber, F.5
Edwards, L.6
Hagan, G.7
Knobil, K.8
Lomas, D.A.9
MacNee, W.10
-
17
-
-
0031001720
-
Alternative projections of mortality and disability by cause 1990-2020: Global burden of disease study
-
Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 1997;349:1498-1504.
-
(1997)
Lancet
, vol.349
, pp. 1498-1504
-
-
Murray, C.J.1
Lopez, A.D.2
-
18
-
-
33846785205
-
C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease
-
Dahl M, Vestbo J,Lange P, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;175:250-255.
-
(2007)
Am J Respir Crit Care Med
, vol.175
, pp. 250-255
-
-
Dahl, M.1
Vestbo, J.2
Lange, P.3
Bojesen, S.E.4
Tybjaerg-Hansen, A.5
Nordestgaard, B.G.6
-
19
-
-
33749998694
-
C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease
-
DOI 10.1136/thx.2006.059808
-
Man SF, Connett JE, Anthonisen NR, Wise RA, Tashkin DP, Sin DD. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax 2006;61:849-853. (Pubitemid 44570304)
-
(2006)
Thorax
, vol.61
, Issue.10
, pp. 849-853
-
-
Man, S.F.P.1
Connett, J.E.2
Anthonisen, N.R.3
Wise, R.A.4
Tashkin, D.P.5
Sin, D.D.6
-
20
-
-
33749817683
-
Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease
-
DOI 10.1164/rccm.200604-506OC
-
Hurst JR, Donaldson GC, Perera WR, Wilkinson TM, Bilello JA, Hagan GW, Vessey RS, Wedzicha JA. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;174:867-874. (Pubitemid 44564786)
-
(2006)
American Journal of Respiratory and Critical Care Medicine
, vol.174
, Issue.8
, pp. 867-874
-
-
Hurst, J.R.1
Donaldson, G.C.2
Perera, W.R.3
Wilkinson, T.M.A.4
Bilello, J.A.5
Hagan, G.W.6
Vessey, R.S.7
Wedzicha, J.A.8
-
21
-
-
38049129336
-
Gender differences in the association between c-reactive protein, lung function impairment, and COPD
-
Olafsdottir IS, Gislason T, Thjodleifsson B, Olafsson I, Gislason D, Jogi R, Janson C. Gender differences in the association between c-reactive protein, lung function impairment, and COPD. Int J Chron Obstruct Pulmon Dis 2007;2:635-642.
-
(2007)
Int J Chron Obstruct Pulmon Dis
, vol.2
, pp. 635-642
-
-
Olafsdottir, I.S.1
Gislason, T.2
Thjodleifsson, B.3
Olafsson, I.4
Gislason, D.5
Jogi, R.6
Janson, C.7
-
22
-
-
34548034720
-
The relationship between inflammatory markers and disability in chronic obstructive pulmonary disease (COPD)
-
DOI 10.3132/pcrj.2007.00047
-
Garrod R, Marshall J, Barley E, Fredericks S, Hagan G. The relationship between inflammatory markers and disability in chronic obstructive pulmonary disease (COPD). Prim Care Respir J 2007;16:236-240. (Pubitemid 47281449)
-
(2007)
Primary Care Respiratory Journal
, vol.16
, Issue.4
, pp. 236-240
-
-
Garrod, R.1
Marshall, J.2
Barley, E.3
Fredericks, S.4
Hagan, G.5
-
23
-
-
34447331959
-
Profiling serum biomarkers in patients with COPD: Associations with clinical parameters
-
DOI 10.1136/thx.2006.064428
-
Pinto-Plata V, Toso J, Lee K, Park D, Bilello J, Mullerova H, De Souza MM, Vessey R, Celli B. Profiling serum biomarkers in patients with COPD: associations with clinical parameters. Thorax 2007;62:595-601. (Pubitemid 47056886)
-
(2007)
Thorax
, vol.62
, Issue.7
, pp. 595-601
-
-
Pinto-Plata, V.1
Toso, J.2
Lee, K.3
Park, D.4
Bilello, J.5
Mullerova, H.6
De Souza, M.M.7
Vessey, R.8
Celli, B.R.9
-
24
-
-
38849205365
-
Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease
-
DOI 10.1164/rccm.200705-678OC
-
Bozinovski S, Hutchinson A, Thompson M, Macgregor L, Black J, Giannakis E, Karlsson AS, Silvestrini R, Smallwood D, Vlahos R, et al. Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;177:269-278. (Pubitemid 351198369)
-
(2008)
American Journal of Respiratory and Critical Care Medicine
, vol.177
, Issue.3
, pp. 269-278
-
-
Bozinovski, S.1
Hutchinson, A.2
Thompson, M.3
MacGregor, L.4
Black, J.5
Giannakis, E.6
Karlsson, A.-S.7
Silvestrini, R.8
Smallwood, D.9
Vlahos, R.10
Irving, L.B.11
Anderson, G.P.12
-
25
-
-
84926426742
-
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: An individual participant meta-analysis
-
DOI 10.1001/jama.294.14.1799
-
Danesh J, Lewington S, Thompson SG, Lowe GD, Collins R, Kostis JB, Wilson AC, Folsom AR, Wu K, Benderly M, et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 2005;294: 1799-1809. (Pubitemid 41434626)
-
(2005)
Journal of the American Medical Association
, vol.294
, Issue.14
, pp. 1799-1809
-
-
Danesh, J.1
Lewington, S.2
Thompson, S.G.3
Lowe, G.D.O.4
Collins, R.5
Brennan, P.6
Chambless, L.7
Hense, H.W.8
Levy, D.9
-
26
-
-
39449106895
-
Increased systemic inflammation is a risk factor for COPD exacerbations
-
DOI 10.1378/chest.07-1342
-
Groenewegen KH, Postma DS, Hop WC, Wielders PL, Schlosser NJ, Wouters EF. Increased systemic inflammation is a risk factor for COPD exacerbations. Chest 2008;133:350-357. (Pubitemid 351272391)
-
(2008)
Chest
, vol.133
, Issue.2
, pp. 350-357
-
-
Groenewegen, K.H.1
Postma, D.S.2
Hop, W.C.J.3
Wielders, P.L.M.L.4
Schlosser, N.J.J.5
Wouters, E.F.M.6
-
27
-
-
0035883488
-
Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease
-
Dahl M, Tybjaerg-Hansen A, Vestbo J, Lange P, Nordestgaard BG. Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:1008-1011. (Pubitemid 32971649)
-
(2001)
American Journal of Respiratory and Critical Care Medicine
, vol.164
, Issue.6
, pp. 1008-1011
-
-
Dahl, M.1
Tybjaerg-Hansen, A.2
Vestbo, J.3
Lance, P.4
Nordestgaard, B.G.5
-
28
-
-
27144526596
-
Airway and systemic inflammation and decline in lung function in patients with COPD
-
DOI 10.1378/chest.128.4.1995
-
Donaldson GC, Seemungal TA, Patel IS, Bhowmik A, Wilkinson TM, Hurst JR, Maccallum PK, Wedzicha JA. Airway and systemic inflammation and decline in lung function in patients with copd. Chest 2005;128:1995-2004. (Pubitemid 41507533)
-
(2005)
Chest
, vol.128
, Issue.4
, pp. 1995-2004
-
-
Donaldson, G.C.1
Seemungal, T.A.R.2
Patel, I.S.3
Bhowmik, A.4
Wilkinon, T.M.A.5
Hurst, J.R.6
MacCallum, P.K.7
Wedzicha, J.A.8
-
29
-
-
69249133317
-
Serum surfactant protein d is steroid sensitive and associated with exacerbations of COPD
-
Lomas DA, Silverman EK, Edwards LD, Locantore NW, Miller BE, Horstman DH, Tal-Singer R. Serum surfactant protein d is steroid sensitive and associated with exacerbations of COPD. Eur Respir J 2009.
-
(2009)
Eur Respir J
-
-
Lomas, D.A.1
Silverman, E.K.2
Edwards, L.D.3
Locantore, N.W.4
Miller, B.E.5
Horstman, D.H.6
Tal-Singer, R.7
-
30
-
-
44449101166
-
The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in COPD
-
Sin DD, Man SF, Marciniuk DD, Ford G, Fitzgerald M, Wong E, York E, Mainra RR, Ramesh W, Melenka LS, et al. The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in COPD. Am J Respir Crit Care Med 2008;177:1207-1214.
-
(2008)
Am J Respir Crit Care Med
, vol.177
, pp. 1207-1214
-
-
Sin, D.D.1
Man, S.F.2
Marciniuk, D.D.3
Ford, G.4
Fitzgerald, M.5
Wong, E.6
York, E.7
Mainra, R.R.8
Ramesh, W.9
Melenka, L.S.10
-
31
-
-
57149112816
-
Evaluation of serum cc-16 as a biomarker for COPD in the eclipse cohort
-
Lomas DA, Silverman EK, Edwards LD, Miller BE, Coxson HO, Tal-Singer R. Evaluation of serum cc-16 as a biomarker for COPD in the eclipse cohort. Thorax 2008;63:1058-1063.
-
(2008)
Thorax
, vol.63
, pp. 1058-1063
-
-
Lomas, D.A.1
Silverman, E.K.2
Edwards, L.D.3
Miller, B.E.4
Coxson, H.O.5
Tal-Singer, R.6
-
32
-
-
34249652351
-
Antielastin autoimmunity in tobacco smoking-induced emphysema
-
DOI 10.1038/nm1583, PII NM1583
-
Lee SH, Goswami S, Grudo A, Song LZ, Bandi V, Goodnight-White S, Green L, Hacken-Bitar J, Huh J, Bakaeen F, et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med 2007;13:567-569. (Pubitemid 46828488)
-
(2007)
Nature Medicine
, vol.13
, Issue.5
, pp. 567-569
-
-
Lee, S.-H.1
Goswami, S.2
Grudo, A.3
Song, L.-Z.4
Bandi, V.5
Goodnight-White, S.6
Green, L.7
Hacken-Bitar, J.8
Huh, J.9
Bakaeen, F.10
Coxson, H.O.11
Cogswell, S.12
Storness-Bliss, C.13
Corry, D.B.14
Kheradmand, F.15
-
33
-
-
51349165795
-
Induction of lung emphysema is prevented by l-arginine-threonine-arginine
-
van Houwelingen AH, Weathington NM, Verweij V, Blalock JE, Nijkamp FP, Folkerts G. Induction of lung emphysema is prevented by l-arginine-threonine- arginine. FASEB J 2008;22:3403-3408.
-
(2008)
FASEB J
, vol.22
, pp. 3403-3408
-
-
Van Houwelingen, A.H.1
Weathington, N.M.2
Verweij, V.3
Blalock, J.E.4
Nijkamp, F.P.5
Folkerts, G.6
|